All articles by Linda Stewart – Page 31
-
NewsBioscientist wins NSF CAREER Award to investigate bacterial toxins, expand inclusion in STEM
Marcos de Moraes has received support to study the molecular mechanisms and evolutionary roles of bacterial toxins known as deaminases, as well as an educational outreach effort aimed at making biosciences open to all, including differently abled persons.
-
NewsKenya achieves elimination of human African trypanosomiasis as a public health problem
The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone.
-
NewsNew network to address malaria among school-aged children in sub-Saharan Africa
A new network aims to improve malaria prevention among school-aged children in sub-Saharan Africa. The new partnership will unite researchers, policymakers, healthcare practitioners and other stakeholders across multiple countries to better understand and address the burden of malaria in children.
-
NewsScientists develop new approach to fighting many viruses at once
Scientists have developed a research pipeline to fuel the development of “universal vaccines,” that would address broad viral families and mutated viral variants.
-
NewsEnvironmental antibiotic resistance unevenly addressed despite growing global risk, study finds
Antibiotic resistance in the environment is a growing and largely overlooked crisis receiving inconsistent attention, according to a new study. Worryingly few studies have explored how antibiotic resistance spreads in the air, oceans or green spaces.
-
NewsGeobiologist Dr. Ilya Bobrovskiy moves to MARUM with his ERC Starting Grant
Geobiologist Dr. Ilya Bobrovskiy, previously employed at the GFZ Helmholtz Centre for Geosciences, is moving to the University of Bremen to establish a research group at MARUM as part of his ERC Starting Grant.
-
NewsNovel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
Non-pharmaceutical interventions such as masking and distancing targeted towards SARS-CoV-2 during the pandemic also decreased circulation rates of and population immunity to common respiratory pathogens in children, a new study shows.
-
NewsCopper antimicrobials can drive antibiotic resistance in bacteria, but there’s a fix, scientists say
Microbiologists have found that heavy use of copper antimicrobials can drive antibiotic resistance in bacteria. However, resistance quickly diminishes without copper exposure, suggesting that copper could help reduce antibiotic resistance if alternated with other measures.
-
NewsInvestigating regional-specific gut microbial distribution: an uncharted territory in disease therapeutics
A new perspective highlights the critical role of region-specific gut microbial distribution across intestinal segments (e.g., duodenum, colon) in regulating host metabolism and immunity, challenging traditional fecal-centric approaches.
-
NewsNational study urges expanded vaccine screening in emergency departments
About 49% of people are unaware of one or more vaccines recommended for them. Further, 86% have not received one or more of these vaccines, according to the first national comprehensive vaccine surveillance study conducted in emergency departments.
-
NewsMaple compound offers new way to fight tooth decay
A new study highlights the potential of using a natural compound from maple to combat the bacteria responsible for tooth decay: Streptococcus mutans. Epicatechin gallate is a powerful and safe alternative to traditional plaque-fighting agents.
-
NewsRevealed: New vaccine target to block malaria transmission
Researchers have visualised a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.
-
NewsScientists home in for a close look at lung infections
A new study has meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist after new treatments.
-
NewsNew European toolkit launched by EU agencies to help eliminate viral hepatitis B and C in prisons
The European Union Drugs Agency (EUDA) and the European Centre for Disease Prevention and Control (ECDC) have jointly produced a European toolkit for the elimination of viral hepatitis in prisons.
-
NewsRNA immunity: A silent defender against viruses in mammals
Researchers propose that small RNA molecules play a direct and specific role in fighting viral infections in mammals. RNA immunity relies on the base-pairing precision of small RNA fragments, such as microRNAs, to recognize and suppress viral genetic material.
-
NewsResearch probes the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis
Postmenopausal osteoporosis (PMOP) is framed as a systemic bone disease driven by estrogen withdrawal, but a new review positions gut dysbiosis and its fermentation products—short-chain fatty acids (SCFAs)—as equally influential regulators of skeletal fate.
-
NewsSweet disguise: the human body hides RNA with sugar coatings
To our immune system, naked RNA is a sign of a viral or bacterial invasion and must be attacked. But our own cells also have RNA. To ward off trouble, our cells clothe their RNA in sugars, a new study reports.
-
NewsNanoparticles that self-assemble at room temperature could transform vaccine delivery
Researchers have engineered polymer-based nanoparticles that form with a simple temperature shift—no harsh chemicals, no specialized equipment, and no processing needed. They can self-assemble at room temperature and deliver RNA to living cells.
-
NewsAP2-domain transcription factor WRI5a-regulated MtABCB1 promotes arbuscule development in mycorrhizal symbiosis
A new study of arbuscular mycorrhizal (AM) symbiosis suggests that the MtABCB1 gene likely influences arbuscule development by modulating the distribution and homeostasis of auxin within symbiotic cells.
-
NewsDisarming a hidden killer: Predicting – and preventing – C. diff before it strikes
Researchers have developed a powerful, personalized modeling framework to predict whether Clostridioides difficile is likely to colonize an individual’s gut, and to test whether specific probiotic therapies might prevent and/or reverse that colonization.